Company Filing History:
Years Active: 2019-2022
Title: Innovations by Marc Buehler in Biomedical Research
Introduction
Marc Buehler is an influential inventor based in Riehen, Switzerland. He has made notable contributions to the field of biomedical research, focusing particularly on groundbreaking methods for addressing complex disorders. With a total of two patents under his name, Buehler is dedicated to advancing scientific understanding and treatment options.
Latest Patents
His recent patents include significant advancements in the treatment and understanding of Autism Spectrum Disorder. The first patent revolves around the "Inhibition of autism spectrum disorder using ribosomal read-through compounds." This innovative approach highlights the potential of read-through compounds in the treatment and prevention of Autism Spectrum Disorder.
The second patent explores "Methods for triggering de novo formation of heterochromatin and or epigenetic silencing with small RNAs." This invention describes a method for the targeted formation of heterochromatin and the induction of epigenetic gene silencing in cells. The methodology includes inhibiting the Paf1 complex in the cell and utilizing small RNAs specifically aimed at regions of the genome requiring heterochromatin formation or epigenetic gene silencing induction.
Career Highlights
Marc Buehler is currently affiliated with the Friedrich Miescher Institute for Biomedical Research, a leading institute known for its cutting-edge research in the life sciences. His work at the institute showcases his commitment to uncovering new avenues for medical advancements.
Collaborations
Throughout his career, Buehler has worked collaboratively with accomplished colleagues, including Veronica Ostapcuk and Katarzyna Kowalik. These partnerships have fostered an environment of shared knowledge and innovation, amplifying the impact of his research in the scientific community.
Conclusion
Marc Buehler's inventions and dedicated research are paving the way for new treatments in the realm of biomedical science. His patents not only showcase his innovative approach but also highlight the collaborative spirit prevalent in modern scientific research. As he continues his work, the hope for improved methods to address critical health issues such as Autism Spectrum Disorder remains bright.